Skip to main content
SpringerLink
Log in

In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like Home

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Dopamine (DA) is critical for motivation, reward, movement initiation, and learning. Mechanisms that control DA signaling have a profound impact on these important behaviors, and additionally play a role in DA-related neuropathologies. The presynaptic SLC6 DA transporter (DAT) limits extracellular DA levels by clearing released DA, and is potently inhibited by addictive and therapeutic psychostimulants. Decades of evidence support that the DAT is subject to acute regulation by a number of signaling pathways, and that endocytic trafficking strongly regulates DAT availability and function. DAT trafficking studies have been performed in a variety of model systems, including both in vitro and ex vivo preparations. In this review, we focus on the breadth of DAT trafficking studies, with specific attention to, and comparison of, how context may influence DAT’s response to different stimuli. In particular, this overview highlights that stimulated DAT trafficking not only differs between in vitro and ex vivo environments, but also is influenced by both sex and anatomical subregions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5:483–494

    Article  CAS  PubMed  Google Scholar 

  2. Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565–598

    Article  CAS  PubMed  Google Scholar 

  3. Keiflin R, Janak PH (2015) Dopamine prediction errors in reward learning and addiction: from theory to neural circuitry. Neuron 88:247–263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, Ching S, Quan N, Stephens RL, Hill ER, Nottoli T, Han DD, Gu HH (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci USA 103:9333–9338

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Thomsen M, Han DD, Gu HH, Caine SB (2009) Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J Pharmacol Exp Ther 331:204–211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Tilley MR, O’Neill B, Han DD, Gu HH (2009) Cocaine does not produce reward in absence of dopamine transporter inhibition. NeuroReport 20:9–12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli A (2014) SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Transl Psychiatry 4:e464

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD (2008) Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci 28:7040–7046

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD (2014) The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proc Natl Acad Sci USA 111:E4779–4788

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD (2005) Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology 49:724–736

    Article  CAS  PubMed  Google Scholar 

  11. DiCarlo GE, Aguilar JI, Matthies HJ, Harrison FE, Bundschuh KE, West A, Hashemi P, Herborg F, Rickhag M, Chen H, Gether U, Wallace MT, Galli A (2019) Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors. J Clin Investig 129:3407–3419

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, Belovich AN, Consortium NAAS, Sahai MA, Cook EH, Gether U, McHaourab HS, Matthies HJ, Sutcliffe JS, Galli A (2013) De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry 18:1315–1323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hansen FH, Skjorringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K, Andreassen TF, Holy M, Hamilton PJ, Neergheen V, Karlsborg M, Newman AH, Pope S, Heales SJ, Friberg L, Law I, Pinborg LH, Sitte HH, Loland C, Shi L, Weinstein H, Galli A, Hjermind LE, Moller LB, Gether U (2014) Missense dopamine transporter mutations associate with adult Parkinsonism and ADHD. J Clin Investig 124:3107–3120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kurian MA, Li Y, Zhen J, Meyer E, Hai N, Christen HJ, Hoffmann GF, Jardine P, von Moers A, Mordekar SR, O’Callaghan F, Wassmer E, Wraige E, Dietrich C, Lewis T, Hyland K, Heales S Jr, Sanger T, Gissen P, Assmann BE, Reith ME, Maher ER (2011) Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol 10:54–62

    Article  CAS  PubMed  Google Scholar 

  15. Kurian MA, Zhen J, Cheng SY, Li Y, Mordekar SR, Jardine P, Morgan NV, Meyer E, Tee L, Pasha S, Wassmer E, Heales SJ, Gissen P, Reith ME, Maher ER (2009) Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile Parkinsonism-dystonia. J Clin Investig 119:1595–1603

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Gerfen CR, Surmeier DJ (2011) Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34:441–466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Meiergerd SM, Patterson TA, Schenk JO (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem 61:764–767

    Article  CAS  PubMed  Google Scholar 

  18. Mayfield RD, Zahniser NR (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol Pharmacol 59:113–121

    Article  CAS  PubMed  Google Scholar 

  19. Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F (2007) Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J 26:2127–2136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71:1222–1232

    Article  CAS  PubMed  Google Scholar 

  21. Chen R, Daining CP, Sun H, Fraser R, Stokes SL, Leitges M, Gnegy ME (2013) Protein kinase Cbeta is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter. J Neurochem 125:663–672

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Luderman KD, Chen R, Ferris MJ, Jones SR, Gnegy ME (2015) Protein kinase C beta regulates the D(2)-like dopamine autoreceptor. Neuropharmacology 89:335–341

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Gowrishankar R, Gresch PJ, Davis GL, Katamish RM, Riele JR, Stewart AM, Vaughan RA, Hahn MK, Blakely RD (2018) Region-specific regulation of presynaptic dopamine homeostasis by D2 autoreceptors shapes the in vivo impact of the neuropsychiatric disease-associated DAT variant Val559. J Neurosci 38:5302–5312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Marcott PF, Gong S, Donthamsetti P, Grinnell SG, Nelson MN, Newman AH, Birnbaumer L, Martemyanov KA, Javitch JA, Ford CP (2018) Regional heterogeneity of D2-receptor signaling in the dorsal striatum and nucleus accumbens. Neuron 98:575–587.e574

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Owens WA, Sevak RJ, Galici R, Chang X, Javors MA, Galli A, France CP, Daws LC (2005) Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem 94:1402–1410

    Article  CAS  PubMed  Google Scholar 

  26. Owens WA, Williams JM, Saunders C, Avison MJ, Galli A, Daws LC (2012) Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism. J Neurosci 32:2637–2647

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289–1297

    Article  CAS  PubMed  Google Scholar 

  28. Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433

    Article  CAS  PubMed  Google Scholar 

  29. Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, Sitte HH, Ramamoorthy S, Shippenberg TS (2014) Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology 86:228–240

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Kivell BM, Ewald AW, Prisinzano TE (2014) Salvinorin A analogs and other kappa-opioid receptor compounds as treatments for cocaine abuse. Adv Pharmacol 69:481–511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Torres GE, Yao W-D, Mohn AR, Quan H, Kim K-M, Levey AI, Staudinger J, Caron MG (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30:121–134

    Article  CAS  PubMed  Google Scholar 

  32. Bjerggaard C, Fog JU, Hastrup H, Madsen K, Loland CJ, Javitch JA, Gether U (2004) Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J Neurosci 24:7024–7036

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Wu S, Fagan RR, Uttamapinant C, Lifshitz LM, Fogarty KE, Ting AY, Melikian HE (2017) The dopamine transporter recycles via a retromer-dependent postendocytic mechanism: tracking studies using a novel fluorophore-coupling approach. J Neurosci 37:9438–9452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Rickhag M, Hansen FH, Sorensen G, Strandfelt KN, Andresen B, Gotfryd K, Madsen KL, Vestergaard-Klewe I, Ammendrup-Johnsen I, Eriksen J, Newman AH, Fuchtbauer EM, Gomeza J, Woldbye DP, Wortwein G, Gether U (2013) A C-terminal PDZ domain-binding sequence is required for striatal distribution of the dopamine transporter. Nat Commun 4:1580

    Article  PubMed  CAS  Google Scholar 

  35. Loder MK, Melikian HE (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278:22168–22174

    Article  CAS  PubMed  Google Scholar 

  36. Holton KL, Loder MK, Melikian HE (2005) Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat Neurosci 8:881–888

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Furman CA, Lo CB, Stokes S, Esteban JA, Gnegy ME (2009) Rab 11 regulates constitutive dopamine transporter trafficking and function in N2A neuroblastoma cells. Neurosci Lett 463:78–81

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Eriksen J, Bjorn-Yoshimoto WE, Jorgensen TN, Newman AH, Gether U (2010) Postendocytic sorting of constitutively internalized dopamine transporter in cell lines and dopaminergic neurons. J Biol Chem 285:27289–27301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sakrikar D, Mazei-Robison MS, Mergy MA, Richtand NW, Han Q, Hamilton PJ, Bowton E, Galli A, Veenstra-Vanderweele J, Gill M, Blakely RD (2012) Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. J Neurosci 32:5385–5397

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Gabriel LR, Wu S, Kearney P, Bellve KD, Standley C, Fogarty KE, Melikian HE (2013) Dopamine transporter endocytic trafficking in striatal dopaminergic neurons: differential dependence on dynamin and the actin cytoskeleton. J Neurosci 33:17836–17846

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Hong WC, Amara SG (2013) Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons. FASEB J 27:2995–3007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sorkina T, Hoover BR, Zahniser NR, Sorkin A (2005) Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6:157–170

    Article  CAS  PubMed  Google Scholar 

  43. Navaroli DM, Stevens ZH, Uzelac Z, Gabriel L, King MJ, Lifshitz LM, Sitte HH, Melikian HE (2011) The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking. J Neurosci 31:13758–13770

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Wu S, Bellve KD, Fogarty KE, Melikian HE (2015) Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant. Proc Natl Acad Sci USA 112:15480–15485

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Gabriel L, Stevens Z, Melikian H (2009) Measuring plasma membrane protein endocytic rates by reversible biotinylation. J Vis Exp. https://doi.org/10.3791/1669

    Article  PubMed  PubMed Central  Google Scholar 

  46. Eriksen J, Rasmussen SG, Rasmussen TN, Vaegter CB, Cha JH, Zou MF, Newman AH, Gether U (2009) Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs. J Neurosci 29:6794–6808

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Block ER, Nuttle J, Balcita-Pedicino JJ, Caltagarone J, Watkins SC, Sesack SR, Sorkin A (2015) Brain region-specific trafficking of the dopamine transporter. J Neurosci 35:12845–12858

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Wakayama S, Kiyonaka S, Arai I, Kakegawa W, Matsuda S, Ibata K, Nemoto YL, Kusumi A, Yuzaki M, Hamachi I (2017) Chemical labelling for visualizing native AMPA receptors in live neurons. Nat Commun 8:14850

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Biermann B, Sokoll S, Klueva J, Missler M, Wiegert JS, Sibarita JB, Heine M (2014) Imaging of molecular surface dynamics in brain slices using single-particle tracking. Nat Commun 5:3024

    Article  CAS  PubMed  Google Scholar 

  50. Rahbek-Clemmensen T, Lycas MD, Erlendsson S, Eriksen J, Apuschkin M, Vilhardt F, Jorgensen TN, Hansen FH, Gether U (2017) Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains. Nat Commun 8:740

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Huff RA, Vaughan RA, Kuhar MJ, Uhl GR (1997) Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax. J Neurochem 68:225–232

    Article  CAS  PubMed  Google Scholar 

  52. Zhu SJ, Kavanaugh MP, Sonders MS, Amara SG, Zahniser NR (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J Pharmacol Exp Ther 282:1358–1365

    CAS  PubMed  Google Scholar 

  53. Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30:79–87

    Article  CAS  PubMed  Google Scholar 

  54. Melikian HE, Buckley KM (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19:7699–7710

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Daniels GM, Amara SG (1999) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274:35794–35801

    Article  CAS  PubMed  Google Scholar 

  56. Bermingham DP, Blakely RD (2016) Kinase-dependent regulation of monoamine neurotransmitter transporters. Pharmacol Rev 68:888–953

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Fagan RR, Kearney PJ, Sweeney CG, Luthi D, Uiterkamp FS, Schicker K, O’Connor LC, Alejandro BS, Sitte HH, Melikian HE. Dopamine transporter trafficking and Rit2 GTPase: in vivo impact and mechanism of action. J Biol Chem (in press)

  58. Sweeney CG, Kearney PJ, Fagan RR, Smith LA, Bolden NC, Zhao-Shea R, Rivera IV, Kolpakova J, Xie J, Gao G, Tapper AR, Martin GE, Melikian HE (2020) Conditional, inducible gene silencing in dopamine neurons reveals a sex-specific role for Rit2 GTPase in acute cocaine response and striatal function. Neuropsychopharmacology 45:384–393

    Article  CAS  PubMed  Google Scholar 

  59. Steinberg SF (2008) Structural basis of protein kinase C isoform function. Physiol Rev 88:1341–1378

    Article  CAS  PubMed  Google Scholar 

  60. Gorentla BK, Vaughan RA (2005) Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation. Neuropharmacology 49:759–768

    Article  CAS  PubMed  Google Scholar 

  61. Boudanova E, Navaroli DM, Melikian HE (2008) Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology 54:605–612

    Article  CAS  PubMed  Google Scholar 

  62. Granas C, Ferrer J, Loland CJ, Javitch JA, Gether U (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J Biol Chem 278:4990–5000

    Article  PubMed  CAS  Google Scholar 

  63. Page G, Peeters M, Najimi M, Maloteaux JM, Hermans E (2001) Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes. J Neurochem 76:1282–1290

    Article  CAS  PubMed  Google Scholar 

  64. Bendor J, Lizardi-Ortiz JE, Westphalen RI, Brandstetter M, Hemmings HC Jr, Sulzer D, Flajolet M, Greengard P (2010) AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. EMBO J 29:2813–2826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Foster DJ, Gentry PR, Lizardi-Ortiz JE, Bridges TM, Wood MR, Niswender CM, Sulzer D, Lindsley CW, Xiang Z, Conn PJ (2014) M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's location. J Neurosci 34:3253–3262

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Shin JH, Adrover MF, Wess J, Alvarez VA (2015) Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens. Proc Natl Acad Sci USA 112:8124–8129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Fischer JF, Cho AK (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203–209

    CAS  PubMed  Google Scholar 

  68. Kantor L, Gnegy ME (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592–598

    CAS  PubMed  Google Scholar 

  69. Kahlig KM, Galli A (2003) Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur J Pharmacol 479:153–158

    Article  CAS  PubMed  Google Scholar 

  70. Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A (2003) Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J Biol Chem 278:12070–12077

    Article  CAS  PubMed  Google Scholar 

  71. Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci USA 102:3495–3500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci USA 97:6850–6855

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE (2001) Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J Neurosci 21:1413–1419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Gulley JM, Doolen S, Zahniser NR (2002) Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem 83:400–411

    Article  CAS  PubMed  Google Scholar 

  75. Johnson LA, Furman CA, Zhang M, Guptaroy B, Gnegy ME (2005) Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Neuropharmacology 49:750–758

    Article  CAS  PubMed  Google Scholar 

  76. Kahlig KM, Lute BJ, Wei Y, Loland CJ, Gether U, Javitch JA, Galli A (2006) Regulation of dopamine transporter trafficking by intracellular amphetamine. Mol Pharmacol 70:542–548

    Article  CAS  PubMed  Google Scholar 

  77. Wheeler DS, Underhill SM, Stolz DB, Murdoch GH, Thiels E, Romero G, Amara SG (2015) Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine. Proc Natl Acad Sci USA 112:E7138–E7147

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Underhill SM, Hullihen PD, Chen J, Fenollar-Ferrer C, Rizzo MA, Ingram SL, Amara SG (2019) Amphetamines signal through intracellular TAAR1 receptors coupled to Galpha13 and GalphaS in discrete subcellular domains. Mol Psychiatry. https://doi.org/10.1038/s41380-019-0469-2

    Article  PubMed  PubMed Central  Google Scholar 

  79. Simon JR, Bare DJ, Ghetti B, Richter JA (1997) A possible role for tyrosine kinases in the regulation of the neuronal dopamine transporter in mouse striatum. Neurosci Lett 224:201–205

    Article  CAS  PubMed  Google Scholar 

  80. Doolen S, Zahniser NR (2001) Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J Pharmacol Exp Ther 296:931–938

    CAS  PubMed  Google Scholar 

  81. Carvelli L, Moron JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, Leeb-Lundberg LM, Merrill G, Lafer EM, Ballou LM, Shippenberg TS, Javitch JA, Lin RZ, Galli A (2002) PI 3-kinase regulation of dopamine uptake. J Neurochem 81:859–869

    Article  CAS  PubMed  Google Scholar 

  82. Garcia BG, Wei Y, Moron JA, Lin RZ, Javitch JA, Galli A (2005) Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 68:102–109

    Article  CAS  PubMed  Google Scholar 

  83. Hoover BR, Everett CV, Sorkin A, Zahniser NR (2007) Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations. J Neurochem 101:1258–1271

    Article  CAS  PubMed  Google Scholar 

  84. Zhu S, Zhao C, Wu Y, Yang Q, Shao A, Wang T, Wu J, Yin Y, Li Y, Hou J, Zhang X, Zhou G, Gu X, Wang X, Bustelo XR, Zhou J (2015) Identification of a Vav2-dependent mechanism for GDNF/Ret control of mesolimbic DAT trafficking. Nat Neurosci 18:1084–1093

    Article  CAS  PubMed  Google Scholar 

  85. Williams JM, Owens WA, Turner GH, Saunders C, Dipace C, Blakely RD, France CP, Gore JC, Daws LC, Avison MJ, Galli A (2007) Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol 5:e274

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  86. Speed N, Saunders C, Davis AR, Owens WA, Matthies HJ, Saadat S, Kennedy JP, Vaughan RA, Neve RL, Lindsley CW, Russo SJ, Daws LC, Niswender KD, Galli A (2011) Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. PLoS ONE 6:e25169

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Littrell OM, Pomerleau F, Huettl P, Surgener S, McGinty JF, Middaugh LD, Granholm AC, Gerhardt GA, Boger HA (2012) Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging 33:427.e1-14

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brudnick Neuropsychiatric Research Institute, Department of Neurobiology, University of Massachusetts Medical School, Worcester, MA, 01605, USA

    Rita R. Fagan, Patrick J. Kearney & Haley E. Melikian

Authors
  1. Rita R. Fagan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick J. Kearney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haley E. Melikian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haley E. Melikian.

Additional information

Special issue in honor of Professor Michael Robinson.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fagan, R.R., Kearney, P.J. & Melikian, H.E. In Situ Regulated Dopamine Transporter Trafficking: There’s No Place Like Home. Neurochem Res 45, 1335–1343 (2020). https://doi.org/10.1007/s11064-020-03001-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-020-03001-6

Keywords

Search

Navigation